American Scientific Resources, Incorporated (ASFX) Research

American Scientific Resources, Incorporated (ASFX) was a company dedicated to the development, manufacturing, and distribution of a diverse range of medical devices and products designed for both pediatric and adult use. Its portfolio encompassed multiple non-contact clinical thermometers, including the Thermofocus 5-in-1 and VeraTemp series. For child safety and well-being, the company offered the Scald Safe Water temperature disc, designed to prevent scalding in baby baths, and WhistleWatch, a monitoring device for children's respiratory patterns. The "Kidz-Med" brand featured a portable ultrasonic nebulizer for treating respiratory ailments like asthma and bronchitis, an orthodontic-nipple-equipped medicine dispenser, and the Mommy Recorder, a voice-recording device to comfort distressed infants. Other offerings aimed at children and parents included the Bip educational DVD series, the comprehensive "Mebby" line (which encompassed breast pumps, BPA-free baby bottles, digital scales, humidifiers, pacifiers, and sterilizers), and "Wee Target," a toilet training aid for young boys. The company also addressed adult medical needs with the "Disintegrator," a home device for the safe destruction of needles and lancets, particularly beneficial for individuals managing conditions such as diabetes or multiple sclerosis. ASFX distributed its offerings via pharmacy and supermarket retailers, medical suppliers, its own e-commerce website, and other online platforms. The firm was headquartered in Weston, Florida. Crucially, American Scientific Resources, Incorporated faced an involuntary petition for Chapter 7 liquidation on February 27, 2012, in the US Bankruptcy Court for the Southern District of Florida. This petition was subsequently approved by the court on March 28, 2012, and the company is currently undergoing liquidation proceedings.

Open American Scientific Resources, Incorporated (ASFX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.